MedTrace Logo

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

NCT00984191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2011-06-27

No results posted yet for this study

Summary

The purpose of this trial is to see if the 99mTechnetium-MIBI SPECT-CT can be a tool for preoperative evaluation of cervical node metastasis in papillary thyroid cancer.

Conditions

  • Papillary Thyroid Cancer

Interventions

RADIATION

99mTc-MIBI SPECT-CT

99mTc-MIBI SPECT-CT for abnormal cervical lymph node

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Napadon Tangjaturonrasme, Otolaryngologist · Department of Otolaryngology , Faculty of Medicine , Chulalongkorn University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984191 on ClinicalTrials.gov